We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Prometic

News List

Prometic strengthens its leadership with a new management structure and the appointment of three new directors firstwordpharma
May 09, 2019
Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or "Corporation") is pleased to announce today a new management structure to provide leadership to the Corporation and ...
Prometic and Shenzen Royal Asset Management close transaction for JV and licensing rights to three p biospectrumasia
August 23, 2017
Deal provides Prometic with an initial $33 million, of which $23 million is receivable in H2 2017
Prometic and SRAM JV to develop and commercialise three drug candidates in China pharmaceutical-technology
April 01, 2017
Prometic Life Sciences has signed a memorandum of terms with Shenzhen Royal Asset Management (SRAM) to establish a joint venture (JV) for the development, manufacture and commercialisation of three drug candidates, PBI-4050, PBI-4547 and PBI-4425, in Chin